# QuantaBricks

> QuantaBricks is an AI-powered molecular discovery and drug design platform. It combines two products — Benchora (natural-language drug hunting: lead optimization, de-novo design) and ChemOrchestra (a no-code AI molecular design workspace with full parameter control) — with an in-house therapeutics pipeline and a molecular longevity factor prediction tool.

QuantaBricks decentralizes computer-aided drug design, making molecular structure analysis, ADMET prediction, and virtual screening accessible without a computational chemistry background.

## Products

- [Benchora](https://benchora.quanta-bricks.com/): Natural-language drug hunting — lead optimization and de-novo molecular design.
- [ChemOrchestra](https://www.quantabricks.xyz/): No-code AI molecular design platform with a workflow builder and advanced parameter control — property prediction, RNA/protein structure modeling, lead optimization.
- [Molecular Longevity Report](https://www.quanta-bricks.com/longevity): ADMET and longevity-factor analysis (antioxidant, anti-inflammatory, vasorelaxation, autophagy induction) for a given molecule.

## Research & Benchmarks

- [Benchmark reports](https://www.quanta-bricks.com/benchmark): Case studies and model evaluations covering AlphaFold, ESMFold, Boltz-2, and virtual screening workflows in real drug discovery programs.
- [Therapeutics pipeline](https://www.quanta-bricks.com/pipeline): AI-designed oncology and CNS programs, including KRAS G12D, BRAF V600E, and EGFR resistance-mutation candidates.

## Education

- [AI Drug Discovery Bootcamp](https://www.quanta-bricks.com/education): Hands-on bootcamps and internship projects in drug and cosmetic chemistry, no coding required.

## Company

QuantaBricks is based in New Jersey, USA. Contact: contact@quanta-bricks.com.